PXS logo

Provexis plc Stock Price

AIM:PXS Community·UK£35.2m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

PXS Share Price Performance

UK£0.015
0.01 (140.00%)
UK£0.015
0.01 (140.00%)
Price UK£0.015

PXS Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Moderate risk with adequate balance sheet.

5 Risks
0 Rewards

Provexis plc Key Details

UK£871.3k

Revenue

UK£442.3k

Cost of Revenue

UK£429.0k

Gross Profit

UK£1.0m

Other Expenses

-UK£603.8k

Earnings

Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
n/a
-0.00026
49.24%
-69.30%
0%
View Full Analysis

About PXS

Founded
1999
Employees
2
CEO
Ian Ford
WebsiteView website
www.provexis.com

Provexis plc, together with its subsidiaries, develops, licenses, and sells functional foods, medical foods, and dietary supplements worldwide. The company offers syrup and powder versions of Fruitflow, a tomato extract that reduces the propensity for aberrant blood clotting typically associated with cardiovascular diseases, such as heart attack and stroke used in various foods, beverages, and dietary supplement formats. It also provides Fruitflow+ Omega-3, a dietary supplement product. The company sells its products through e-commerce website and distributors. Provexis plc was founded in 1999 and is based in Reading, the United Kingdom.

Recent PXS News & Updates

We're Not Very Worried About Provexis' (LON:PXS) Cash Burn Rate

Dec 10
We're Not Very Worried About Provexis' (LON:PXS) Cash Burn Rate

Recent updates

No updates